Items where Author is "Gholami, Mohammad Hossein"

Warning The system is temporarily closed to updates for reporting purpose.
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 18.

Article

Mirzaei, Sepideh and Paskeh, Mahshid Deldar Abad and Okina, Elena and Gholami, Mohammad Hossein and Hushmandi, Kiavash and Hashemi, Mehrdad and Kalu, Azuma and Zarrabi, Ali and Nabavi, Noushin and Rabiee, Navid and Sharifi, Esmaeel and Karimi-Maleh, Hassan and Ashrafizadeh, Milad and Kumar, Alan Prem and Wang, Yuzhuo (2022) Molecular landscape of LncRNAs in prostate cancer: a focus on pathways and therapeutic targets for intervention. Journal of Experimental and Clinical Cancer Research, 41 (1). ISSN 1756-9966

Mirzaei, Sepideh and Gholami, Mohammad Hossein and Hushmandi, Kiavash and Hashemi, Farid and Zabolian, Amirhossein and Canadas, Israel and Zarrabi, Ali and Nabavi, Noushin and Aref, Amir Reza and Crea, Francesco and Wang, Yuzhuo and Ashrafizadeh, Milad and Kumar, Alan Prem (2022) Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer (Journal of Hematology & Oncology, (2022), 15, 1, (18), 10.1186/s13045-022-01235-1). Journal of Hematology and Oncology, 15 (1). ISSN 1756-8722

Ashrafizadeh, Milad and Saebfar, Hamidreza and Gholami, Mohammad Hossein and Hushmandi, Kiavash and Zabolian, Amirhossein and Bikarannejad, Pooria and Hashemi, Mehrdad and Daneshi, Salman and Mirzaei, Sepideh and Sharifi, Esmaeel and Kumar, Alan Prem and Khan, Haroon and Heydari Sheikh Hossein, Hamid and Vosough, Massoud and Rabiee, Navid and Kumar Thakur, Vijay and Makvandi, Pooyan and Mishra, Yogendra Kumar and Tay, Franklin R. and Wang, Yuzhuo and Zarrabi, Ali and Orive, Gorka and Mostafavi, Ebrahim (2022) Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance. Expert Opinion on Drug Delivery, 19 (4). pp. 355-382. ISSN 1742-5247 (Print) 1744-7593 (Online)

Ashrafizadeh, Milad and Paskeh, Mahshid Deldar Abad and Mirzaei, Sepideh and Gholami, Mohammad Hossein and Zarrabi, Ali and Hashemi, Farid and Hushmandi, Kiavash and Hashemi, Mehrdad and Nabavi, Noushin and Crea, Francesco and Ren, Jun and Klionsky, Daniel J. and Kumar, Alan Prem and Wang, Yuzhuo (2022) Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. Journal of Experimental and Clinical Cancer Research, 41 (1). ISSN 1756-9966

Mirzaei, Sepideh and Gholami, Mohammad Hossein and Hushmandi, Kiavash and Hshemi, Farid and Zabolian, Amirhossein and Canadas, Israel and Zarrabi, Ali and Nabavi, Noushin and Aref, Amir Reza and Crea, Francesco and Wang, Yuzhuo and Ashrafizadeh, Milad and Kumar, Alan Prem (2022) The long and short non-coding RNAs modulating EZH2 signaling in cancer. Journal of Hematology and Oncology, 15 (1). ISSN 1756-8722

Mirzaei, Sepideh and Gholami, Mohammad Hossein and Hashemi, Farid and Zabolian, Amirhossein and Farahani, Mahdi Vasheghani and Hushmandi, Kiavash and Zarrabi, Ali and Goldman, Aaron and Ashrafizadeh, Milad and Orive, Gorka (2022) Advances in understanding the role of P-gp in doxorubicin resistance: molecular pathways, therapeutic strategies, and prospects. Drug Discovery Today, 27 (2). pp. 436-455. ISSN 1359-6446 (Print) 1878-5832 (Online)

Paskeh, Mahshid Deldar Abad and Mehrabi, Atefeh and Gholami, Mohammad Hossein and Zabolian, Amirhossein and Ranjbar, Ehsan and Saleki, Hossein and Ranjbar, Adnan and Hashemi, Mehrdad and Ertas, Yavuz Nuri and Hushmandi, Kiavash and Mirzaei, Sepideh and Ashrafizadeh, Milad and Zarrabi, Ali and Samarghandian, Saeed (2022) EZH2 as a new therapeutic target in brain tumors: molecular landscape, therapeutic targeting and future prospects. Biomedicine and Pharmacotherapy, 146 . ISSN 0753-3322 (Print) 1950-6007 (Online)

Paskeh, Mahshid Deldar Abad and Mirzaei, Sepideh and Gholami, Mohammad Hossein and Zarrabi, Ali and Zabolian, Amirhossein and Hashemi, Mehrdad and Hushmandi, Kiavash and Ashrafizadeh, Milad and Aref, Amir Reza and Samarghandian, Saeed (2021) Cervical cancer progression is regulated by SOX transcription factors: revealing signaling networks and therapeutic strategies. Biomedicine and Pharmacotherapy, 144 . ISSN 0753-3322 (Print) 1950-6007 (Online)

Mirzaei, Sepideh and Gholami, Mohammad Hossein and Ang, Hui Li and Hashemi, Farid and Zarrabi, Ali and Zabolian, Amirhossein and Hushmandi, Kiavash and Delfi, Masoud and Khan, Haroon and Ashrafizadeh, Milad and Sethi, Gautam and Kumar, Alan Prem (2021) Pre-clinical and clinical applications of small interfering rnas (Sirna) and co-delivery systems for pancreatic cancer therapy. Cells, 10 (12). ISSN 2073-4409

Ashrafizadeh, Milad and Mirzaei, Sepideh and Gholami, Mohammad Hossein and Hashemi, Farid and Zabolian, Amirhossein and Raei, Mehdi and Hushmandi, Kiavash and Zarrabi, Ali and Voelcker, Nicolas H. and Aref, Amir Reza and Hamblin, Michael R. and Varma, Rajender S. and Samarghandian, Saeed and Arostegi, I. J. and Alzola, M. and Kumar, Alan Prem and Thakur, Vijay Kumar and Nabavi, Noushin and Makvandi, Pooyan and Tay, Franklin R. and Orive, Gorka (2021) Hyaluronic acid-based nanoplatforms for Doxorubicin: a review of stimuli-responsive carriers, co-delivery and resistance suppression. Carbohydrate Polymers, 272 . ISSN 0144-8617 (Print) 1879-1344 (Online)

Mirzaei, Sepideh and Abadi, Asal Jalal and Gholami, Mohammad Hossein and Hashemi, Farid and Zabolian, Amirhossein and Hushmandi, Kiavash and Zarrabi, Ali and Entezari, Maliheh and Aref, Amir Reza and Khan, Haroon and Ashrafizadeh, Milad and Samarghandian, Saeed (2021) The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: possible molecular targets. European Journal of Pharmacology, 908 . ISSN 0014-2999 (Print) 1879-0712 (Online)

Mirzaei, Sepideh and Saebfar, Hamidreza and Gholami, Mohammad Hossein and Hashemi, Farid and Zarrabi, Ali and Zabolian, Amirhossein and Entezari, Maliheh and Hushmandi, Kiavash and Samarghandian, Saeed and Aref, Amir Reza and Ashrafizadeh, Milad and Khan, Haroon (2021) MicroRNAs regulating SOX2 in cancer progression and therapy response. Expert Reviews in Molecular Medicine, 23 . ISSN 1462-3994

Mirzaei, Sepideh and Gholami, Mohammad Hossein and Zabolian, Amirhossein and Saleki, Hossein and Farahani, Mahdi Vasheghani and Hamzehlou, Soodeh and Far, Fatemeh Bakhtiari and Sharifzadeh, Seyed Omid and Samarghandian, Saeed and Khan, Haroon and Aref, Amir Reza and Ashrafizadeh, Milad and Zarrabi, Ali and Sethi, Gautam (2021) Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: new hope in the fight against cancer. Pharmacological Research, 171 . ISSN 1043-6618 (Print) 1096-1186 (Online)

Mirzaei, Sepideh and Gholami, Mohammad Hossein and Hashemi, Farid and Zabolian, Amirhossein and Hushmandi, Kiavash and Rahmanian, Vahid and Entezari, Maliheh and Girish, Yarabahally R. and Sharath Kumar, Kothanahally S. and Aref, Amir Reza and Makvandi, Pooyan and Ashrafizadeh, Milad and Zarrabi, Ali and Khan, Haroon (2021) Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: approaching to a new era of cancer chemotherapy. Life Sciences, 277 . ISSN 0024-3205 (Print) 1879-0631 (Online)

Mirzaei, Sepideh and Mohammadi, Aliasghar Tabatabaei and Gholami, Mohammad Hossein and Hashemi, Farid and Zarrabi, Ali and Zabolian, Amirhossein and Hushmandi, Kiavash and Makvandi, Pooyan and Samec, Marek and Liskova, Alena and Kubatka, Peter and Nabavi, Noushin and Aref, Amir Reza and Ashrafizadeh, Milad and Khan, Haroon and Najafi, Masoud (2021) Nrf2 signaling pathway in cisplatin chemotherapy: potential involvement in organ protection and chemoresistance. Pharmacological Research, 167 . ISSN 1043-6618 (Print) 1096-1186 (Online)

Ashrafizadeh, Milad and Gholami, Mohammad Hossein and Mirzaei, Sepideh and Zabolian, Amirhossein and Haddadi, Amirabbas and Farahani, Mahdi Vasheghani and Kashani, Sharareh Hosseinzadeh and Hushmandi, Kiavash and Najafi, Masoud and Zarrabi, Ali and Ahn, Kwang Seok and Khan, Haroon (2021) Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: new insight to proliferation and metastasis. Life Sciences, 270 . ISSN 0024-3205 (Print) 1879-0631 (Online)

Abadi, Asal Jalal and Zarrabi, Ali and Gholami, Mohammad Hossein and Mirzaei, Sepideh and Hashemi, Farid and Zabolian, Amirhossein and Entezari, Maliheh and Hushmandi, Kiavash and Ashrafizadeh, Milad and Khan, Haroon and Kumar, Alan Prem (2021) Small in size, but large in action: micrornas as potential modulators of pten in breast and lung cancers. Biomolecules, 11 (2). ISSN 2218-273X

Mirzaei, Sepideh and Gholami, Mohammad Hossein and Mahabady, Mahmood Khaksary and Nabavi, Noushin and Zabolian, Amirhossein and Banihashemi, Seyed Mohammad and Haddadi, Amirabbas and Entezari, Maliheh and Hushmandi, Kiavash and Makvandi, Pooyan and Samarghandian, Saeed and Zarrabi, Ali and Ashrafizadeh, Milad and Khan, Haroon (2021) Pre-clinical investigation of STAT3 pathway in bladder cancer: paving the way for clinical translation. Biomedicine and Pharmacotherapy, 133 . ISSN 0753-3322 (Print) 1950-6007 (Online)

This list was generated on Tue Nov 29 22:01:04 2022 +03.